Questions and responses 45th Parliament, 1st session May 26, 2025, to present

With regard to expenditures on consultants by Health Canada, the Public Health Agency of Canada, the Canadian Institutes of Health Research, the Patented Medicine Prices Review Board, and the Canadian Food Inspection Agency, since January 1, 2023, broken down by year: (a) what is the total amount of expenditures incurred by each on consultants; and (b) what are the details of all such contracts under object codes 0431 (Scientific consultants), 0446 (Training consultants), 0473 (Information technology and telecommunications consultants), 0491 (Management consulting), 0422 (Engineering consultants – Construction), or 0423 (Engineering consultants – Other), including, for each, (i) the amount, (ii) the vendor, (iii) the date of the contract, (iv) the duration of the contract, (v) the description of the services provided, (vi) the reason or purpose of the contract, (vii) whether the contract was sole sourced?

With regard to Health Canada’s Consumer Product Safety Program since 2019-20 and broken down by fiscal year: (a) how many complaints, notifications or consumer product incident reports were received by Health Canada regarding manufactured non-compliant products in the Canadian market; (b) of the products in (a), how many were (i) manufactured in Canada, (ii) imported into Canada from elsewhere, broken down by country of primary manufacturer; (c) of the products in (a), what North American Industry Classification System subsector did these products fall under; (d) how many of the consumer product incident reports in (a) relate to ASTM F2057-23 – Standard Safety Specification for Clothing Storage Units; (e) what was the average response timeline to the complainant that submitted a consumer product incident report, broken down by year; (f) how many consumer product incident reports have not received a response; (g) does the complainant receive confirmation that a full investigation was completed, and of the outcome of this investigation; (h) how many investigations are currently open, broken down by the year the consumer product incident report was submitted; (i) how many products have been removed from the Canadian market based on consumer product incident reports, broken down by the year the consumer product incident report was submitted; and (j) what administrative monetary penalties or enforcement actions have been issued through the Consumer Product Safety Program, broken down by (i) the year the complaint was received, (ii) the manufacturer or importer name, (iii) the amount of the fine, (iv) whether a compliance agreement was implemented, (v) whether the fine was paid or unpaid?

With regard to Health Canada, the Public Health Agency of Canada and product recalls since 2018: (a) which sections or secretariats within Health Canada or the Public Health Agency of Canada decide if a product is recalled, and what are the details of each, including the number of employees and their titles; (b) what is the process for initiating a product recall, including who initiates the recall and the metric used to determine if a product should be recalled; (c) for each recall since 2018, (i) who initiated the recall, (ii) what was the reason for the recall, (iii) how were Canadians notified of the recall, (iv) what was the risk of injury from the product, (v) how many Canadians were injured from the product, (vi) how many Canadians died from the product, (vii) what was the product; and (d) are products recalled because of fraudulent claims, and, if so, (i) who is responsible for determining if a product made a fraudulent claim, (ii) what is the process used to determine if a claim is fraudulent, (iii) what are the penalties for a fraudulent claim, (iv) how many fraudulent claims were identified but the product wasn't recalled, (v) what is the product name and the date for each fraudulent claim in (d)(iv)?

With regard to the “Subsection 56(1) class exemption in relation to urgent public health need sites in the provinces and territories” that requires, through condition 11 of the exemption, for the provincial and territorial Ministers of Health to submit quarterly reports to the Office of Controlled Substances by the 15th of the month following the end of each quarter, since 2023: (a) how many quarterly reports have been received by the Office of Controlled Substances since the exemption came into effect, broken down by province or territory and by reporting quarter; (b) on what date was each report received by the Office of Controlled Substances, broken down by province or territory and by reporting quarter; (c) which provinces or territories failed to submit a quarterly report by the deadline and for which reporting quarter; (d) for each instance where a quarterly report was submitted after the deadline, how many days late was the report received, broken down by province or territory and by reporting quarter; and (e) what steps, if any, has the government taken in response to late or missing quarterly reports?